DGAP-News: Medios AG / Key word(s): Investment
18.01.2017 / 11:59
In the future, all software development activities performed by stocklisted Medios AG and all of the group’s other companies (Medios Pharma GmbH that specializes in the wholesale distribution of specialty pharmaceutical drugs as well as Medios Manufaktur GmbH, the special manufacturer for customized pharmaceuticals for patients) will be bundled at Medios Digital GmbH.
Thanks to its unique, innovative commercial platform in the specialty pharma field, the Medios Group sees itself as a competent link between pharmaceutical companies, pharmacies and other pharmaceutical clients, such as manufacturing companies. The full digitalization of the commercial platform will be one of the main focuses of Medios Digital GmbH. In the future, all partner pharmacies and clients will, among other things, have the opportunity to access the latest offers online and also to plan and place their orders online.
About Medios AG
Phone: +49 30 232 5668 0
This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future results may significantly deviate from currently expected results, specifically due to various risk factors and uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no responsibility whatsoever for updating the forward-looking statements contained in this notification.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Phone:||+49 30 232 566 – 800|
|Fax:||030 / 8321 8377|
|Listed:||Regulated Market in Frankfurt (General Standard), Hamburg; Regulated Unofficial Market in Dusseldorf|
|End of News||DGAP News Service|